Difference between revisions of "Part:BBa K320007"
| Line 2: | Line 2: | ||
<partinfo>BBa_K320007 short</partinfo> | <partinfo>BBa_K320007 short</partinfo> | ||
| − | This BioBricks permit the expression of the protein P25. | + | This BioBricks permit the expression of the protein P25. |
| − | The ookinete (plasmodium state in mosquito's gut) has been intensively studied by scientists, looking for an ideal transmission-blocking vaccine target. IGEM EPFL team's interest goes toward the ookinete surface membrane proteins Pfs25 and Pfs28. In fact, it has been shown that the binding of specific antibodies to these surface proteins was fatal to more than 99% of the parasites | + | The ookinete (plasmodium state in mosquito's gut) has been intensively studied by scientists, looking for an ideal transmission-blocking vaccine target. IGEM EPFL team's interest goes toward the ookinete surface membrane proteins Pfs25 and Pfs28 (link to other biobrick). In fact, it has been shown that the binding of specific antibodies to these surface proteins was fatal to more than 99% of the parasites reference. Indeed, P25 and P28 seem to be essential to the ookinete survival, the crossing of the midgut epithelium and its transformation into an oocyst. |
| + | |||
| + | The team decided to design Asaia to express a soluble form of these 2 P-proteins. It could seem contra-intuitive to provide more of these proteins (by expression in Asaia), which are very important for the parasite survival, migration, and development. But our hypothesis is that adding a lot of these proteins in a soluble form will compete with the parasite surface protein and prevent the interaction necessary to its transmission. Because the functions of P25 and P28 are redundant, both proteins need to be inhibited or outcompeted to efficiently block the malaria transmission more on our [http://2010.igem.org/wiki/index.php?title=Team:EPF_Lausanne/Project/Background website]. | ||
| − | |||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
Revision as of 20:22, 25 October 2010
Constitutive expression of P25
This BioBricks permit the expression of the protein P25.
The ookinete (plasmodium state in mosquito's gut) has been intensively studied by scientists, looking for an ideal transmission-blocking vaccine target. IGEM EPFL team's interest goes toward the ookinete surface membrane proteins Pfs25 and Pfs28 (link to other biobrick). In fact, it has been shown that the binding of specific antibodies to these surface proteins was fatal to more than 99% of the parasites reference. Indeed, P25 and P28 seem to be essential to the ookinete survival, the crossing of the midgut epithelium and its transformation into an oocyst.
The team decided to design Asaia to express a soluble form of these 2 P-proteins. It could seem contra-intuitive to provide more of these proteins (by expression in Asaia), which are very important for the parasite survival, migration, and development. But our hypothesis is that adding a lot of these proteins in a soluble form will compete with the parasite surface protein and prevent the interaction necessary to its transmission. Because the functions of P25 and P28 are redundant, both proteins need to be inhibited or outcompeted to efficiently block the malaria transmission more on our [http://2010.igem.org/wiki/index.php?title=Team:EPF_Lausanne/Project/Background website].
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 62
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]